Using the FIV model, it has been previously demonstrated that FIV infection phenotypically and functionally activates CD4+CD25+Foxp3+ Treg cells during both the acute and chronic stages of infection and these cells are capable of inhibiting CD4+ and CD8+ T cell effector responses. This evidence concerns the gene CD8A and infection.